[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620139":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":23,"responsibleParty":39,"collaborators":43,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":10,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":10,"maxAge":10,"enrollmentInfo":64,"targetDuration":67,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":76,"overallStatus":80,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Zhujiang Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients diagnosed with cerebral arteriovenous malformations and intracranial aneurysms",null,"Patients diagnosed with concomitant cerebral arteriovenous malformations and intracranial aneurysms by digital subtraction angiography (DSA), and\u002For magnetic resonance imaging (MRI), and\u002For computed tomographic angiography (CTA).",[13],{"name":14,"affiliation":5,"role":15},"Chuanzhi Duan, MD","PRINCIPAL_INVESTIGATOR",[17],{"name":18,"role":19,"phone":20,"phoneExt":21,"email":22},"Xin Feng, MD","CONTACT","13681134001","+86","13681134001@163.com",[24],{"facility":25,"status":10,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Zhujiang Hospital, Southern Medical University","Guangzhou","Guangdong","528400","China","CN",{"type":32,"coordinates":33},"Point",[34,35],113.25,23.11667,{"lat":35,"lon":34},[38],{"name":18,"role":19,"phone":20,"phoneExt":21,"email":22},{"type":40,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Duan Chuanzhi","Professor",[44,46,48,50,52,54],{"name":45,"class":6},"Beijing Tiantan Hospital",{"name":47,"class":6},"The First Affiliated Hospital of Zhengzhou University",{"name":49,"class":6},"The First Affiliated Hospital of Nanchang University",{"name":51,"class":6},"Second Affiliated Hospital of Nanchang University",{"name":53,"class":6},"Shenzhen Second People's Hospital",{"name":55,"class":6},"Guangdong 999 Brain Hospital","100620139","cerebral-arteriovenous-malformation-with-aneurysm-epidemiology-clinical-features-and-prognosis-100620139",false,"NCT07353736","Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis","Hemodynamic Mechanisms, Clinical Profiles, and Prognostic Factors in Patients With Cerebral Arteriovenous Malformations and Intracranial Aneurysms: An Observational Cohort Study","Inclusion Criteria:\n\n* Patients diagnosed with cerebral arteriovenous malformation and intracranial aneurysm confirmed by CTA, MRA, and\u002For DSA;\n* Availability of complete clinical and imaging data;\n* Provision of written informed consent by the patient or their legally authorized representative to participate in the study and undergo follow-up;\n* Not concurrently participating in any other clinical trials that may interfere with the outcomes of this study.\n\nExclusion Criteria:\n\n* Previous complete occlusion of the aneurysm and\u002For arteriovenous malformation prior to enrollment;\n* Coexistence of other cerebrovascular diseases such as moyamoya disease, cerebral cavernous malformation, cerebral venous sinus thrombosis, etc.;\n* Absence of DSA imaging data or poor image quality that precludes accurate evaluation of key anatomical and hemodynamic parameters of the AVM and intracranial aneurysm.","ALL",{"count":65,"type":66},630,"ESTIMATED","2 Years","OBSERVATIONAL","The study is a multicenter, prospective cohort study designed to assess the natural history, clinical safety and efficacy of various treatment strategies in patients with cerebral arteriovenous malformations (AVMs) and intracranial aneurysms.",[71,72,73,74,75],"Cerebral Arteriovenous Malformation","Intracranial Arterial Diseases","Intra Cerebral Hemorrhage","Intracranial Aneurysm","Brain Diseases",[77,78,79,71,74],"Hemodynamic Mechanisms","Prospective cohort study","Endovascular treatment","NOT_YET_RECRUITING","2026-01-17",{"date":83,"type":84},"2026-01-20","ACTUAL",{"date":86,"type":66},"2026-02-01",{"date":88,"type":66},"2030-12-30",{"name":41,"class":6},1]